Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans
- Resource Type
- Source
- Retrovirology, Vol 9, Iss Suppl 2, p P354 (2012)
Retrovirology - Subject
lcsh:Immunologic diseases. Allergy Liposome business.industry medicine.drug_class medicine.medical_treatment Immunogenicity Monophosphoryl Lipid A Bioinformatics Monoclonal antibody Virology Epitope Infectious Diseases Immune system Antigen Poster Presentation Medicine lcsh:RC581-607 business Adjuvant - Language
- ISSN
- 1742-4690